Document is current

Any future updates will be listed below

Letter to the editor: Long-term safety and efficacy of pegvisomant monotherapy for acromegaly: final data from the full ACROSTUDY cohort

Crossref DOI link: https://doi.org/10.1007/s11102-026-01687-5

Published Online: 2026-05-06

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark